Symphony Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/v53jjtdk30v9ic1xuibx08dt.pdf

Key Takeaways


Performance & Profitability

Nrupesh Shah: "Symphony clearly believes that top line is vanity, profit is sanity, but cash flow and cash profit is really a purity and reality."

Subsidiary Health & Turnaround

Achal Bakeri: "It has taken longer than we had anticipated for a variety of reasons. But we believe that there too, it is like a hockey stick curve. And once we sort of touch the bottom, which we believe we have. Going forward, it will only -- the performance will only be significantly better."

The Defaulting Distributor

Nrupesh Shah: "this was the party having a turnover in excess of ₹2,000 crores at a group level -- they were our distributor for more than 12 years. And until last summer, they were having impeccable track record in terms of the repayment. So, this has come as a major surprise to us also."

Product & Category Expansion

Achal Bakeri: "This product is an impulse buy. It is not a planned purchase, because it is largely a portable product. So, the day the mercury goes up to 42, 44, whatever, they go out to the market buy and it is a plug-and-play product."

Real Estate & Capital Allocation


Industry Structure & Competitive Position

Achal Bakeri: "Our business is very tremendously linked to how the summer temperatures are. And we had a good summer in '24. The previous summers were not all that good."

Guidance & Commitments

CommitmentSpecificsTimeline
New cooler billingBilling and delivery of 17 new air cooler models to beginDecember quarter (Q3 FY25)
GSK China loan repaymentAdditional repayment of outstanding ~₹52 crores loanClear visibility, no specific date
Real estate monetizationDivestment of Sindhu Bhavan Road land parcel (~₹30 crores) and flatNo specific timeline
India growth trajectory"Very respectable double-digit CAGR" going forwardMedium to long term
Data center product entryChina subsidiary product under development~2 years if successful ("fingers crossed")
Distributor recoveryLegal proceedings (Section 138 and further) underwayUncertain; "our guess is as good as yours"

Key Metrics

MetricQ2 FY25
Stand-alone revenue₹259 cr, up 32% YoY
Stand-alone PAT₹67 cr, up 36% YoY; includes ~₹2 cr additional income tax on treasury capital gains
Stand-alone EBITDA margin27.8%, up from 26.8% YoY
Stand-alone H1 FY25 revenue₹632 cr, up 72% YoY; highest ever H1, 49% above previous peak of ₹423 cr in Sep'22
Stand-alone H1 FY25 PAT₹136 cr, up 112% YoY; highest ever H1, previous peak ₹83 cr in Sep'19
Stand-alone return on net worth31%, vs 21% previous year
Stand-alone trailing 12-month core capital employednegative ₹3 cr monthly average, vs positive ₹55 cr previous year
Treasury as on 30 Sep 2024₹685 cr, up from ₹589 cr YoY; after ~₹100 cr buyback and interim dividend
Consolidated revenue₹315 cr, up 15% YoY
Consolidated PAT₹56 cr, up 61% YoY
Consolidated PAT margin17.7%, up 500 bps YoY
Consolidated H1 FY25 revenue₹846 cr, up 47% YoY; highest ever H1, above previous peak of ₹603 cr in Sep'22
Consolidated H1 FY25 EBITDA₹175 cr, vs ₹70 cr previous year; margin 20.6%, up 840 bps
Consolidated H1 FY25 PAT₹144 cr; nearly matches full FY24 consol PAT of ₹148 cr
Consolidated ROCE93% on core capital employed, vs 37% previous year
Consolidated return on net worth33%, vs 15% previous year
IMPCO Mexico H1 FY25 revenue₹122 cr, up 14% YoY; PAT ₹14 cr vs ₹8 cr
GSK China H1 FY25 revenue₹41 cr, up from ₹23 cr; PAT ₹5 cr
GSK China Q2 FY25 revenue₹25 cr, vs ₹11 cr YoY
GSK China loan repayment in H1 FY25~₹11 cr repaid out of ₹63 cr including interest; balance outstanding ~₹52 cr
Symphony Brazil H1 FY25 revenue₹19 cr, vs ₹7 cr
Symphony Brazil Q2 FY25 revenue₹18 cr, vs ₹6 cr YoY
Climate Technologies H1 FY25 revenue₹74 cr, down from ₹91 cr; PAT negative ₹17 cr, in line with last year
Subsidiaries combined H1 FY25 turnover₹256 cr, up 12% from ₹229 cr; EBITDA ₹23 cr vs ₹7 cr; PAT ₹7 cr vs negative ₹10 cr
Second interim dividend₹2 per share; total H1 shareholder payout ₹110 cr, 77% of consol PAT
Overdue receivable from large distributor~₹44 cr net outstanding for summer 2024 supplies; legal proceedings initiated
Stand-alone negative capital employed as of Sep 2024₹171 cr, vs negative ₹70 cr
Stand-alone trailing 12-month PBIT₹252 cr on negative capital employed
Consolidated core capital employed as on 30 Sep 2024₹114 cr; trailing 12-month ₹286 cr
Surplus real estate identified for monetization~₹31 cr market value (Thol surplus land ~₹61 cr, Sindhu Bhavan Road parcel ~₹30 cr); reclassified to assets held-for-sale
Real estate continuing as fixed assets~₹25 cr historical cost; market value ~₹104 cr
New air cooler models launched17 models; billing and delivery to start from December quarter